Surgery Bests Endovascular Therapy for Most Limb-Threatening Ischemia Patients
CHICAGO — Surgical revascularization led to fewer major adverse limb events and deaths compared with endovascular therapy in patients with chronic limb-threatening ischemia, according to the prospective randomized BEST-CLI trial. After a median follow-up of 2.7 years, the primary composite outcome of major adverse limb events and death from any cause occurred in 42.6% of …
Surgery Bests Endovascular Therapy for Most Limb-Threatening Ischemia Patients Read More »









